Regulators of Slc4 bicarbonate transporter activity by Ian M. Thornell & Mark O. Bevensee
REVIEW
published: 12 June 2015
doi: 10.3389/fphys.2015.00166
Frontiers in Physiology | www.frontiersin.org 1 June 2015 | Volume 6 | Article 166
Edited by:
Mauricio Antonio Retamal,
Universidad del Desarrollo, Chile
Reviewed by:
Ira Kurtz,
University of California, Los Angeles,
USA
Harpreet Singh,
Drexel University College of Medicine,
USA
Antonius Baartscheer,
Academic Medical Center,
Netherlands
*Correspondence:
Mark O. Bevensee,
Department of Cell, Developmental
and Integrative Biology, University of
Alabama at Birmingham, 1720 2nd
Ave. S, 812 MCLM, 1918 University
Blvd., Birmingham, AL 35294-0005,
USA
bevensee@uab.edu
†
Present Address:
Ian M. Thornell, Michael J. Welsh
Laboratory, Department of Internal
Medicine, Howard Hughes Medical
Institute, University of Iowa, Iowa City,
USA
Specialty section:
This article was submitted to
Membrane Physiology and Membrane
Biophysics,
a section of the journal
Frontiers in Physiology
Received: 26 January 2015
Accepted: 15 May 2015
Published: 12 June 2015
Citation:
Thornell IM and Bevensee MO (2015)
Regulators of Slc4 bicarbonate
transporter activity.
Front. Physiol. 6:166.
doi: 10.3389/fphys.2015.00166
Regulators of Slc4 bicarbonate
transporter activity
Ian M. Thornell 1 † and Mark O. Bevensee 1, 2, 3, 4*
1Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA,
2Nephrology Research and Training Center, University of Alabama at Birmingham, Birmingham, AL, USA, 3Center of Glial
Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA, 4Civitan International Research Center,
University of Alabama at Birmingham, Birmingham, AL, USA
The Slc4 family of transporters is comprised of anion exchangers (AE1-4), Na+-coupled
bicarbonate transporters (NCBTs) including electrogenic Na/bicarbonate cotransporters
(NBCe1 and NBCe2), electroneutral Na/bicarbonate cotransporters (NBCn1 and
NBCn2), and the electroneutral Na-driven Cl-bicarbonate exchanger (NDCBE), as well
as a borate transporter (BTR1). These transporters regulate intracellular pH (pHi) and
contribute to steady-state pHi, but are also involved in other physiological processes
including CO2 carriage by red blood cells and solute secretion/reabsorption across
epithelia. Acid-base transporters function as either acid extruders or acid loaders, with
the Slc4 proteins moving HCO− either into or out of cells. According to results from3
both molecular and functional studies, multiple Slc4 proteins and/or associated splice
variants with similar expected effects on pHi are often found in the same tissue or
cell. Such apparent redundancy is likely to be physiologically important. In addition
to regulating pHi, a HCO
− transporter contributes to a cell’s ability to fine tune the3
intracellular regulation of the cotransported/exchanged ion(s) (e.g., Na+ or Cl−). In
addition, functionally similar transporters or splice variants with different regulatory profiles
will optimize pH physiology and solute transport under various conditions or within
subcellular domains. Such optimization will depend on activated signaling pathways
and transporter expression profiles. In this review, we will summarize and discuss both
well-known and more recently identified regulators of the Slc4 proteins. Some of these
regulators include traditional second messengers, lipids, binding proteins, autoregulatory
domains, and less conventional regulators. The material presented will provide insight
into the diversity and physiological significance of multiple members within the Slc4 gene
family.
Keywords: acid-base, anion exchanger, cotransporter, pH, signaling
Introduction
The Solute carrier 4 (Slc4) gene products are part of a family of bicarbonate transporters (BTs)
that include Na+-independent anion exchangers (AEs), as well as Na+-coupled bicarbonate
transporters (NCBTs). NCBTs are further categorized into (i) Na/bicarbonate cotransporters
(NBCs) that are either electrogenic (NBCe1 and NBCe2) or electroneutral (NBCn1 and
NBCn2), and (ii) the electroneutral Na-driven Cl-bicarbonate exchanger (NDCBE). BTs regulate
intracellular pH (pHi) and can alter extracellular pH (pHo) by functioning as either acid loaders
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that transport HCO−3 (or CO
2−
3 ) out of cells, or acid extruders
that transport these ions into cells.
BTs also contribute to the cellular homeostasis of other ions
and associated properties in addition to H+ and HCO−3 . For
example, the Cl-HCO3 exchanger (Cl− into cells, HCO
−
3 out)
can act in concert with the Na-H exchanger (Na+ in, H+ out)
to move net NaCl into cells, thereby increasing intracellular
Na+ (Na+i ) and Cl
− (Cl−i ), but with no net movement of
acid-base equivalents. Activating this pair of transporters in
shrunken cells promotes cellular water uptake in a process
known as volume regulatory increase (Hallows and Knauf, 1994).
As another example, NCBTs contribute to the regulation of
Na+i and intracellular Ca
2+ (Ca2+i ), and can directly influence
membrane excitability. Such regulation is particularly evident
in the heart where there is both electroneutral NBC activity
(Dart and Vaughan-Jones, 1992; Lagadic-Gossmann et al., 1992;
Leem et al., 1999) and electrogenic NBC activity (Camilión
de Hurtado et al., 1995, 1996; Aiello et al., 1998). During
ischemia and subsequent reperfusion of the heart, Na-coupled
acid-base transporters inmyocytes that are activated by ischemia-
induced intracellular acidosis can elevate Na+i , which in turn
can decrease and even reverse the Na-Ca exchanger, thereby
elevating Ca2+i and promoting Ca
2+-mediated injury. Indeed,
NBC activity contributes to the pHi recovery of heart cells with
reperfusion following ischemia/hypoxia (Vandenberg et al., 1993;
Schafer et al., 2000; van Borren et al., 2004; Ten Hove et al.,
2005; De Giusti et al., 2011; Fantinelli et al., 2014), but can
also promote damaging Na+i and Ca
2+
i overload (Schafer et al.,
2000; Ten Hove et al., 2005). An antibody reported to inhibit
human-heart NBCe1-B can protect the systolic and diastolic
functions of rat heart during reperfusion (Khandoudi et al.,
2001). However, cardioprotection from NBC blockade is not
always evident depending on experimental conditions (Ten Hove
et al., 2005). Consistent with the findings by Khandoudi et al.
(2001), an antibody targeting the third extracellular loop of
NBCe1 that inhibits NBCe1-B (De Giusti et al., 2011) limited the
infarct size and protected the systolic and diastolic functions of
reperfused isolated rat hearts (Fantinelli et al., 2014). Curiously,
the compound S0859, which inhibits multiple NCBTs in the heart
(Ch’en et al., 2008), limited the infarct size, but did not protect
the systolic and diastolic functions (Fantinelli et al., 2014). In
addition to contributing to pHi and ion homeostasis, electrogenic
NBC activity produces an outward current that contributes to the
resting membrane potential of cardiac cells and can shorten the
action potential duration (Aiello et al., 1998; Villa-Abrille et al.,
2007; De Giusti et al., 2011).
BTs not only contribute to ion homeostasis and steady-
state pHi of cells, but also promote solute secretion and/or
reabsorption by epithelia. For example, NBCe1-A in the
basolateral membrane of cells in the renal proximal tubule
(Boron and Boulpaep, 1983) is responsible for up to 90% HCO−3
reabsorption by the kidney. Basolateral NBCe1-B contributes
to HCO−3 secretion by the pancreas (Muallem and Loessberg,
1990). Apical NDCBE works in conjunction with the apical
anion exchanger pendrin to account for thiazide-sensitive NaCl
reabsorption in the cortical collecting duct of kidney (Leviel
et al., 2010). BTs also have roles ancillary to pHi regulation and
solute transport. For example, the erythrocyte AE1 (eAE1) is
responsible for the chloride (Hamburger) shift in erythrocytes
that facilitates CO2 carriage in the blood from systemic to lung
capillaries. NCBTs such as NBCe1, NBCn1, and NDCBE elicit
pHo shifts in the nervous system that can modulate neuronal
firing (Chesler, 2003).
Key advances in understanding the molecular nature of
BTs came when Kopito and Lodish (1985) first cloned the
cDNA encoding an anion exchanger (eAE1), and Romero et al.
(1997) first cloned the cDNA of a NCBT (NBCe1-A). From
additional cloning studies of other BTs, it became apparent
that each family member has multiple variants that arise from
alternative promoters or splicing. Nearly all of the variability
occurs within the cytoplasmic amino (N)- and/or carboxy (C)-
terminal domain(s) (Boron et al., 2009; Parker and Boron, 2013).
These variable domains are potential targets for intracellular
regulators that modulate specific transporter activity, thereby
tightly controlling associated HCO−3 transport and pHi changes.
A regulator can alter a BT’s transport activity by changing
either transport biophysics (i.e., KM and Vmax), transporter
expression, or perhaps transport stoichiometry. Consequently,
BT activity can be optimized for a given cell type depending
on the BTs expressed and the signaling pathways and regulators
either present or activated. There is considerable interest in
understanding how Slc4 family members and their variants are
regulated, thereby providing insight into the role of these variants
in normal and abnormal physiology.
In this review, we will present our current understanding of
regulatory mechanisms of the cloned BTs. We will first briefly
review the molecular physiology of BTs, with an emphasis on
areas pertinent to cell signaling. We will then examine each
family member with an emphasis on functional importance and
specific modes of regulation.
Molecular Physiology
The BT family consists of 10 genes that encode Slc4 proteins,
which can be divided into the following three groups:
Na+-independent AEs, Na+-dependent anion exchangers (i.e.,
NCBTs), and a borate transporter. The AEs consist of AE1-4
(encoded by Slc4a1-3,9). AE1-3 are acid loaders that normally
exchange 1 Cl− into cells for 1 HCO−3 out of cells. At least AE1
can also mediate sulfate/H+ cotransport (Milanick and Gunn,
1984) and oxalate/H+ cotransport (Jennings and Adame, 1996)
in exchange for 1 Cl−. The function of AE4 is not entirely clear,
and there is evidence that the transporter may be Na+ dependent
(Parker and Boron, 2013).
The electrogenic NCBTs include NBCe1 (Slc4a4) and NBCe2
(Slc4a5). Electrogenic NBCs are typically reported to cotransport
1 Na+ and either 2 or 3 HCO−3 . Recently however, it has been
discovered that CO2−3 instead of 2 HCO
−
3 appears to be the
transported species for NBCe1 (Lee et al., 2011; Moss et al., 2014).
CO2−3 transport into cells can have important consequences, and
is predicted to lead to a rise in extracellular PCO2, as discussed
for such transport in the brain (Grichtchenko and Chesler, 1994;
Voipio, 1998; McAlear and Bevensee, 2004). This PCO2 increase
occurs because extracellular HCO−3 is rapidly converted into
more CO2−3 and H
+ (pK ∼ 10.4). However, because the H+
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increase is disproportionately larger than the HCO−3 decrease,
equilibration requires the two to react and form more CO2 and
H2O. This production of extracellular CO2 and its subsequent
rapid diffusion may be a valuable route for efficiently removing
acid equivalents from metabolically active tissue (Voipio, 1998).
For a 1:3 Na:HCO−3 stoichiometry, CO
2−
3 likely transports with
a single HCO−3 (Zhu et al., 2013). For transport into cells, the
energetically favorable inward electrochemical gradient for Na+
drives transport.
The remaining NCBT members that complete the family
are electroneutral. Slc4a7 encodes the electroneutral Na/HCO3
cotransporter (NBCn1), which normally extrudes acid by
cotransporting 1 Na+ and 1 HCO−3 into cells. Slc4a8 encodes
the Na-driven Cl-HCO3 exchanger (NDCBE), which extrudes
acid utilizing the electrochemical energy of 1 Na+ into cells
to drive the exchange of HCO−3 into cells for 1 Cl
− out of
cells. In the transport process, two intracellular acid equivalents
are neutralized, and this is likely achieved by the transport
of 1 CO2−3 (Grichtchenko and Boron, 2002). Slc4a10 encodes
the electroneutral Na/HCO3 cotransporter (NBCn2), which
normally extrudes acid by cotransporting 1 Na+ and 1 HCO−3
into cells, but with an associated futile Cl− self-exchange
(Parker et al., 2008; Damkier et al., 2010). In early literature,
this transporter was named a Na-driven Cl-HCO3 exchanger
(NCBE). The transport mode of NBCn2 (NCBE) appears
complex with a Cl− dependence that may depend on transport
direction, species of the transporter, and/or expression system
(see Majumdar and Bevensee, 2010; Parker and Boron, 2013).
The remaining BT is the Slc4a11-encoded borate transporter,
which is a Na+-coupled base transporter capable of Na-H
exchange in mammalian cells (Jalimarada et al., 2013; Ogando
et al., 2013; Kao et al., 2014). This borate transporter, along with
AE4 described above, are the least functionally understood of all
the BTs.
Structural information is available for BTs, particularly for
AE1, but also for NCBTs that are 28-34% homologous to
AE1 (Romero et al., 2004; Parker and Boron, 2013). The N-
terminal 40% of AE1 is the cytosolic domain involved in binding
other proteins and regulators, whereas the remaining 60% of
the protein is the C-terminal membrane domain involved in
ion transport (Reithmeier et al., 1996). Based on considerable
data from proteolysis, labeling, and mutagenesis studies, AE1
is predicted to have 14 transmembrane domains with most
spanning the membrane, and the N and C termini located
in the cytosol (Cordat and Reithmeier, 2014). Using similar
approaches and mapping onto the predicted topology of AE1,
investigators have developed similar models for NCBTs such as
NBCe1 (Zhu et al., 2010a,b; Kurtz and Zhu, 2013a,b; Parker
and Boron, 2013), although there are likely structural differences
among these transporters (Zhu et al., 2010a; Parker and Boron,
2013). A challenge in the field is to identify the structural
similarities—or perhaps core structure—of BTs, and then the
structural differences that define their functional uniqueness.
An early 3D crystal structure of the C-terminal membrane
domain of AE1 resolved to 20Å revealed a dimer that contains
a cytoplasmic region that likely directs substrate to a membrane
region for translocation across the membrane (Wang et al., 1994;
Reithmeier et al., 1996). The structure of the N-terminal cytosolic
domain of eAE1 resolved to 2.6 Å revealed an interlinking N-
terminal dimerization site (Zhang et al., 2000), and a similar
structure resolved to 2.1 Å of this domain missing its disordered
regions was obtained at neutral pH (Shnitsar et al., 2013).
The subsequent crystal structure of the dimeric C-terminal
membrane domain at 7.5 Å supported these models, and also
revealed a surprising similarity to the structure of the prokaryotic
ClC chloride channel, which functions as a Cl-H exchanger
(Yamaguchi et al., 2010; Hirai et al., 2011). These proteins have
an inverted structural repeat of 5 transmembrane domains that is
common among other transporters from different gene families
including the Na/leucine cotransporter LeuT. More recently,
Barneaud-Rocca et al. (2013) reported a similar homology
model of the membrane domain of AE1 based on the crystal
structure of the bacterial uracil/H symporter UraA, and provided
evidence that specific transmembrane domains (e.g., 3, 5, and
8) form the ion-translocation pathway (Barneaud-Rocca et al.,
2013). Cordat and Reithmeier (2014) provide a more detailed
review of the aforementioned structures of AE1. Although a
high-resolution crystal structure has not been solved for any
NCBT, the N terminus of NBCe1-A resolved to 3Å reveals
an interlinking N-terminal dimerization site (Gill and Boron,
2006) similar to that for AE1. Because of the similarity between
AE1 and NCBTs, the structures of ClC and UraA used to
model AE1 will also be useful in developing structural models
of NCBTs.
In this review, we focus on AE1, AE2, NBCe1, NBCn1,
NDCBE, and NBCn2 because their modes of regulation are the
best characterized to date. Alper et al. (2002), Romero et al.
(2004), Parker and Boron (2013), and Cordat and Reithmeier
(2014) provide a more in-depth discussion of BT family members
beyond the scope of regulation.
AE1 (Slc4a1) and AE2 (Slc4a2)
During the cloning era, one of the early cDNAs identified
encoded themurine erythrocyte AE1 (eAE1) (Kopito and Lodish,
1985). eAE1 is commonly known as band 3 protein because
it is the third band resolved when total erythrocyte protein
is separated by gel electrophoresis. AE1 normally functions
as an acid loader by exchanging 1 extracellular Cl− for 1
intracellular HCO−3 , but can transport in the opposite direction
by changing the ion gradients (e.g., by removing extracellular
Cl−) as described below for erythrocytes.
In erythrocytes, AE1 is an integral component of the Jacobs-
Stewart cycle, which is responsible for increasing the total
CO2-carrying capacity of blood from the systemic circulation
to the lungs, and allowing large amounts of this CO2 to be
carried in the form of HCO−3 (Boron, 2012). In brief, about
two-thirds of CO2 that enters the erythrocytes is hydrolyzed
to H+ and HCO−3 — mainly through the action of carbonic
anhydrase (CA). eAE1-mediated Cl-HCO3 exchange, which is
also known as the Cl− or Hamburger shift, prevents the rate-
limiting accumulation of intracellular HCO−3 by transporting the
HCO−3 out of the erythrocytes. AE1 also contributes to the CO2-
and pH-dependent oxygen-carrying capacity of hemoglobin—
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also known as the Bohr effect. About 25% of total protein in
erythrocytes is eAE1 (Fairbanks et al., 1971).
AE1 is also densely expressed in the basolateral membrane
of α-intercalated cells in distal nephron segments of the kidney
(Alper et al., 1989). Kidney AE1 (kAE1) lacks the N-terminal
65-amino acid residues found in eAE1 (Figure 1). In the distal
nephron, kAE1 promotes basolateral uptake of intracellular
HCO−3 that is formed from apical H
+ secretion for subsequent
urinary excretion. AE1 mRNA has also been detected in the heart
(Kudrycki et al., 1990; Richards et al., 1999) and colon (Kudrycki
et al., 1990) where the protein’s role is less defined.
AE2 is found in the basolateral membrane of most epithelia.
AE2 is functionally similar to AE1 in having a 1:1 Cl−:HCO−3
exchange stoichiometry. There are three AE2 variants (Figure 2)
that derive from alternate promoters, and they are designated by
the letters a, b, and c (e.g., AE2a). AE2b and AE2c each have
two additional variants designated 1 (AE2b1 and AE2c1) and 2
(AE2b2 and AE2c2) that arise from either overlapping promoter
sequences (for AE2b) or splicing (for AE2c). The N termini of the
AE2 variants are much longer than the corresponding N termini
of either AE1 variant. AE2a is ubiquitous among tissue types.
AE2b is less ubiquitous and densely expressed in stomach tissue.
FIGURE 1 | Alignment of AE1 variants. kAE1 is identical to eAE1 except for
missing the N-terminal 65 residues.
FIGURE 2 | Alignment of the cytoplasmic N termini of AE2 variants. AE2
variants are identical except for differences at the N terminus. Common
residues are shown in light gray. The different N termini are defined by 17
residues for AE2a (white), 3 residues for AE2b1 (black), 8 residues for AE2b2
(gray), a shortened N terminus for AE2c1, and 32 residues attached to a
shortened N terminus for AE2c2 (hatched).
AE2c is expressed exclusively in stomach tissue (Wang et al.,
1996).
Carbonic Anhydrase
Carbonic anhydrase (CA) is an enzyme that catalyzes the net
reversible reaction CO2 + H2O ↔ H2CO3, which is in rapid
equilibrium with HCO−3 and H
+. In the presence of CA, the
rate of the hydration reaction is nearly limited by diffusion. It
is clear that CA activity promotes the formation or removal of
HCO−3 that can influence BT activity. Endogenous CA isozyme
II (CAII) in HEK293 cells appears to keep AE1 maximally
active based on the observations that AE1 is inhibited by either
applying the CA inhibitor acetazolamide or co-expressing a
dominant negative CAII, but unaffected by co-expressing wild-
type CAII (Sterling et al., 2001). Sowah and Casey (2011)
presented evidence that active CAII fused to the C terminus
of AE1 stimulates AE1-mediated changes in intracellular pH
and chloride. In this study, the dominant-negative effect of
a catalytically inactive CAII implicates a physical interaction
between CAII and AE1. In exploring the functional interplay
between CA in AE activity, investigators have provided evidence
that CAII directly interacts with AE1 to form a “metabolon” by
binding to the short 33-residue C terminus of AE1. It has been
proposed that the proximity of CAII to AE1 provides localized
generation or removal of HCO−3 to adjust AE1 activity. However,
binding of CAII to AE1, and its functional implications remain
controversial.
There is experimental evidence that both supports and refutes
a physical interaction between CA and AE. Results consistent
with a direct interaction come from solid phase binding assays
with purified CAII and a C-terminal 33-residue peptide of
AE1 conjugated to GST (GST-AE1), which can be detected
by ELISA using an antibody to GST (Vince and Reithmeier,
1998). GST-AE1 (10 nM) interacted with immobilized CAII
under physiological conditions of pH and ionic strength,
and the binding rate increased by either raising the GST-
AE1 concentration or lowering the pH and ionic strength.
Furthermore, an antibody to the C-terminal residues inhibited
the CAII-AE1 interaction. The binding site within AE1 for
immobilized CAII was identified as residues 887DADD in a
mutagenesis study and based on the ability of mutant untagged
AE1 constructs to compete with wild-type GST-AE1 for binding
(Vince and Reithmeier, 2000). Results from additional early
studies also provide support for a direct CA-AE interaction. For
example, in the aforementioned CAII-AE1 study with HEK293
cells, mutating the putative CA binding domain of AE1 reduced
the exchanger activity (Sterling et al., 2001).
However, results from more recent studies do not support
CAII binding directly to the C terminus of AE1. In a binding
assay similar to that described above, Piermarini et al. (2007)
replicated the finding that the GST-tagged C terminus of
AE1 bound to immobilized CAII to a greater extent than
the GST alone, however untagged AE1 did not bind. When
reciprocal experiments were performed with either immobilized
AE1, GST-AE1, or GST, soluble CAII displayed undetectable
binding to untagged AE1, and bound to the fusion protein
with approximately half the apparent affinity as to GST
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alone. Using surface plasma resonance to investigate potential
transient interactions, the authors found that the CAII inhibitor
acetazolamide (positive control), but not the untagged AE1 C-
terminal construct interacted with immobilized CAII (Piermarini
et al., 2007). The group concluded that GST-tagged C-terminal
AE1 constructs and GST itself in the mobile phase bind to
immobile CAII, while non-tagged constructs do not. The authors
did not rule out the existence of an AE1-CAII metabolon, but
concluded that it would be independent of the putative C-
terminal domain of AE1. Similar results were obtained with
CAII and the putative CAII-binding domains at the C termini
of NBCe1 and NDCBE (Piermarini et al., 2007). These results
sound a word of caution when assessing results from binding
assays using labeled protein.
More recent evidence against direct binding of CAII to
AE1 was obtained by FRET analysis using tsA201 cells co-
transfected with the optimized FRET pair CAII-CyPet and
YPet-AE1 (Al-Samir et al., 2013). Using single-channel confocal
microscopy to examine the cross-sectional distribution of each
fluorophore-conjugated protein, the authors found that AE1
was predominantly expressed in the plasma membrane, while
CAII was homogenously expressed throughout the cell. CAII-
CyPet and YPet-AE1 did not interact based on FRET analysis.
In positive-control experiments, FRET was observed in cells
transfected with the following two constructs: AE1 conjugated to
either YPet at the N terminus or CyPet at the C terminus.
Glycophorin A
Glycophorin A (GPA) is a single membrane passing
sialoglycoprotein of 131 residues that is enriched in erythrocytes
(for a review, see Chasis and Mohandas, 1992). GPA contains
antigenic determinants of the MNS blood group. Co-expressing
AE1 with GPA —but not glycophorin B or C— enhanced both
AE1 expression and AE1-mediated 36Cl− uptake in Xenopus
laevis oocytes (Groves and Tanner, 1992, 1994). Different
regions of GPA are responsible for increasing AE1 expression
and function. For example, mutating extracellular residues
61–70 of GPA decreased the activity of AE1, while mutating the
cytoplasmic domain of GPA inhibited trafficking of the protein
to the cell surface (Young and Tanner, 2003). Erythrocytes that
lack eAE1 also lack GPA. These data are consistent with AE1
functioning as a chaperone-like protein and recruiting GPA to
the plasma membrane, where it then stimulates the transporter
(Hassoun et al., 1998). There appears to be a mutual dependency
between AE1 and GPA for proper expression. As suggested by
Groves and Tanner (1992), GPA influences AE1 biosynthesis,
and may synchronize increased plasma membrane expression of
active AE1 with maturation of the erythrocyte.
GPA stimulation of AE1 may account for the observation that
some AE1 mutations cause recessive distal renal tubular acidosis
and hemolytic anemia, but retain normal anion transport in
erythrocytes. One such AE1 mutant, G701D, displays reduced
expression and function (36Cl− uptake) compared to wild-type
AE1 when expressed in oocytes (Tanphaichitr et al., 1998; Young
and Tanner, 2003). However, co-expressing GPA increased both
expression and function of the G701D mutant to levels seen
with wild-type AE1. These oocyte data provide a mechanistic
explanation for the normal anion transport function of G701D
AE1 in erythrocytes containing GPA, but not in the distal kidney
where α-intercalated cells lack GPA.
Glyceraldehyde-3-phosphate Dehydrogenase
Many glycolytic enzymes, including glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), aldolase, phosphofructokinase, lactate
dehydrogenase, and pyruvate kinase bind to either AE1 itself or
AE1-associated proteins (Chu and Low, 2006; Campanella et al.,
2008). With the exception of GAPDH, the influence of glycolytic
enzymes on AE1 activity is poorly understood. GAPDH catalyzes
the conversion of glyceraldehyde-3-phosphate to D-glycerate-
1,3-bisphosphate in the sixth step of glycolysis. GAPDH
stimulated eAE1 expression in the basolateral membrane of
MDCKI cells (Su et al., 2011). The C terminus of AE1 is
responsible for the interaction. kAE1, but not a variant truncated
at the C terminus by 11 residues, bound GAPDH in a yeast
2-hybrid screen (Su et al., 2011). GAPDH also interacts with
eAE1 from rat erythrocytes and kAE1 from rat liver based on co-
immunoprecipitation results (Su et al., 2011). GAPDH also binds
to AE2 through a common anion exchanger C-terminal motif
DEYxE (Su et al., 2011), although the functional consequences
of this GADPH-AE2 interaction have not been demonstrated.
Adaptor Protein-1
Adaptor Protein-1 (AP-1) facilitates the exit of cargo proteins
from the trans-Golgi by promoting the binding of clathrin. An
siRNA-mediated decrease in the µ1A subunit of AP-1 inhibited
the surface expression of co-transfected kAE1 in HEK293T cells
(Sawasdee et al., 2010). In a similar study on MDCK1 cells, µ1A
siRNA caused intracellular retention of human kAE1 (Almomani
et al., 2012). Basolateral targeting of kAE1 was rescued by
co-transfecting an siRNA-resistant µ1A subunit. In the same
MDCK1 study, similar siRNA results were obtained for the µ1B
subunit of AP-1. The AP-1 interaction with kAE1 requires the
transporter’s C terminus. The C-terminal 36 residues of kAE1
(bait) bound to the µ1A subunit of AP-1 in a yeast two-hybrid
screen of a human kidney cDNA library (Sawasdee et al., 2010).
AP-1 binding was confirmed and assigned to the kAE1 motif
904YDEV based on results from mutagenesis.
Src-family Kinases
Src-family kinases are tyrosine kinases encoded by the Src
gene, and their phosphorylation of AE1 stimulates rapid
internalization of the transporter (Yannoukakos et al., 1991;
Williamson et al., 2008). In kAE1-expressing MDCK1 cells,
kAE1 residues Y359 and Y904 were not phosphorylated
under basal conditions (Williamson et al., 2008). However,
treating the cells with the phosphatase inhibitor pervanadate
caused phosphorylation of these two residues, and subsequent
internalization of AE1. A variety of Src-family kinase inhibitors
blocked this pervanadate effect. Curiously, the kAE1 point
mutants Y359A and Y904A —both of which cannot be
phosphorylated— displayed intracellular retention. These data
are consistent with both the type of residue at position 359
and 904 and its phosphorylation state (by Src-family kinases)
modulating plasma membrane expression of AE1. The authors
proposed that a stimulus (e.g., a change in pHi) that shifts
the balance of tyrosine kinase and phosphatase activities could
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alter kAE1 activity. This mechanism might be physiologically
important, and responsible for basolateral AE1 stimulation in
α-intercalated kidney cells that promotes transepithelial acid
secretion during metabolic acidosis, and inhibition that reduces
acid secretion during metabolic alkalosis.
Protein 4.2
Protein 4.2 is an ATP-binding membrane protein found in
erythrocytes. Protein 4.2 maintains stability and integrity of the
erythrocyte membrane based on the observation that patients
with protein 4.2 deficiencies present with spherocytosis and
hemolytic anemia (Sung et al., 1992). In co-expression studies,
protein 4.2 stimulated eAE1-mediated 36Cl− uptake, and the
proteins co-immunoprecipitated (Toye et al., 2005). Three
mutant protein 4.2s that cause hereditary spherocytosis were also
assayed for binding and function. Two of these proteins, the
Tozeur and Komatsu protein 4.2 mutants, did not stimulate or
bind eAE1, and also failed to traffic to the membrane (Toye et al.,
2005). The other mutant (Nippon) did traffic to the membrane
and had similar stimulatory effects on eAE1 as wild-type protein
4.2— a finding consistent with proper trafficking of protein 4.2
being required for full AE1 stimulation. Themechanism bywhich
protein 4.2 stimulates eAE1 at the membrane is not clear, and
may involve either an increase in AE1 expression or transporter
activity.
Protein 4.1
TheN paralog of protein 4.1 is associated with the cytoskeleton in
erythrocytes and provides structural rigidity to the membrane by
stabilizing the spectrin-actin interaction (Baines et al., 2014). It is
well established that the cytoplasmic domain of the erythrocyte
AE1 protein binds protein 4.1 (Pasternack et al., 1985; Jöns and
Drenckhahn, 1992). Protein 4.1 binds dimeric AE1 in forming
a protein 4.1-GPC junctional complex, which also includes the
proteins adducin, p55, and Rh (van den Akker et al., 2010).
However, protein 4.1 regulation of AE1 is less established. Protein
4.1 may contribute to the confirmation of AE1, or regulate
transport activity/expression in association with other regulatory
proteins, e.g., through crosslinking (Baines et al., 2014). It is
worth noting that the B paralog of protein 4.1 has been reported
to bind NBCe1 in the kidney proximal tubule in association with
p55 (Terada et al., 2007). Thus, protein 4.1 regulation of BTs
may not be restricted to AE1. Protein 4.1 may also stimulate the
activity of NCBTs by altering their conformation or attracting
other regulatory proteins.
Nephrin
Nephrin is a protein necessary for proper glomerular filtration,
and is required for kAE1 expression in glomeruli. Native kAE1
expression is inhibited in human glomeruli with the nephrin
mutation NPHS1(FinMaj) (Wu et al., 2010). Furthermore,
transfecting wild-type nephrin into podocytes from these
glomeruli restored kAE1 expression. According to results
from a yeast two-hybrid screen of a human kidney cDNA
library, a C-terminal region of AE1 (877–911) binds nephrin—
a finding confirmed in immunoprecipitation studies with
HEK293 cells heterologously expressing AE1 mutants. Mutual
expression is further evident from the observation that
nephrin expression is reduced in the AE1-knockout mouse
(Wu et al., 2010).
Regulators of cloned AE1 variants are shown in Figure 3.
FIGURE 3 | Regulators of AE1. The general position(s) of known or
potential target site(s) within AE1 for each regulator is/are shown.
Stimulatory effects are depicted by green arrows and inhibitory effects are
depicted by red lines. These effects involve changes in transport function
and/or plasma membrane expression, and may be variant dependent. The
target site of protein 4.2 is unknown within the cytosolic N terminus of AE1.
The AE1 topology is based on that presented in Cordat and Reithmeier
(2014). AE1, anion exchanger 1; AP-1, adapter protein-1; CA, carbonic
anhydrase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GPA,
glycophorin A.
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FIGURE 4 | Alignment of NBCe1 variants. NBCe1 variants are identical
except for differences at the N- and/or C termini, and/or the
inclusion/exclusion of a 9-residue cassette within the cytoplasmic N-terminal
region. Modified with permission from Thornell et al. (2012).
NBCe1 (Slc4a4)
NBCe1 variants are found in many tissues where they are
responsible for pHi regulation, as well as solute absorption
and secretion by epithelia. As depicted in Figure 4, NBCe1-A
contains a different N terminus than NBCe1-B/C, and NBCe1-C
contains a different C terminus than NBCe1-A/B. NBCe1-D is
identical to NBCe1-A, except for the absence of the amino-acid
sequence RMFSNPDNG found within the common N-terminal
region of NBCe1-A/B/C (i.e., after the variable N-terminal
region and before the transmembrane region in Figure 4).
NBCe1-E is identical to NBCe1-B, but lacks the aforementioned
RMFSNPDNG amino acid sequence. The function of NBCe1-
D and -E remains to be examined. NBCe1-A/B/C —and
presumably the D and E variants— have either a 1:2 or 1:3
Na+:HCO−3 stoichiometry.
NBCe1-A plays a major role in HCO−3 reabsorption in the
proximal tubule of the kidney. Filtered HCO−3 and secreted
H+ into the tubule lumen are converted to CO2 and H2O in
a net reaction catalyzed by luminal CAIV activity. Generated
CO2 in the tubule lumen diffuses into the epithelial cell where
intracellular CAII converts the CO2 plus H2O back into H+
and HCO−3 . The H
+ is secreted into the tubule lumen for
subsequent reactions with more HCO−3 . The intracellular HCO
−
3
is reabsorbed into the blood via a basolateral NBCe1-A (Boron
and Boulpaep, 1983) with a 1:3 stoichiometry (Soleimani et al.,
1987).
NBCe1-B is also located in the basolateral membrane of
epithelial cells, and has been shown to contribute to HCO−3
secretion in many tissues, including the pancreas (Muallem and
Loessberg, 1990) and airway (Garnett et al., 2011; Shan et al.,
2012). In these epithelia, the inward transport of net-negative
charge and HCO−3 helps establish the electrical gradient and
HCO−3 chemical gradient that drive HCO
−
3 secretion across
the apical membrane. The electrical gradient can also drive
the apical secretion of additional anions, particularly Cl−. In
addition to transporting solutes across epithelia, NBCe1-B/C
contribute to general pHi shifts, which are especially significant
in the nervous system where corresponding changes in pHo
can modulate neuronal firing (Chesler, 2003). The transporter
in glial cells such as astrocytes plays a particularly important
role in coupling pH changes with voltage changes. More
specifically, following neuronal firing, elevated extracellular K+
depolarizes the membrane of astrocytes, thereby stimulating the
electrogenic NBCe1. This NBCe1-mediated HCO−3 transport
alkalinizes the astrocyte, as well as acidifies the extracellular
space that tends to dampen further neuronal activity. Neurons
also express NCBTs, particularly electroneutral ones such as
NBCn1 and NDCBE (Majumdar and Bevensee, 2010). Thus,
NBCe1 is likely the dominant NCBT responsible for the pHi
physiology of astrocytes and activity-evoked pHo changes,
whereas neuronal electroneutral NCBTs contribute to the pHi
physiology of neurons independent of voltage changes and
therefore make a smaller contribution to activity-evoked pHo
changes. However, this profile is likely an oversimplification
based on the more-recent evidence that neurons can also
exhibit functional electrogenic NBC activity (Majumdar, 2009;
Majumdar and Bevensee, 2010; Svichar et al., 2011).
Carbonic Anhydrase
Carbonic anhydrase (CA) catalyzes the slow reaction H+ +
HCO−3 ↔ CO2 + H2O. While monitoring NBCe1 short-
circuit current, Gross et al. (2002) found that the CA inhibitor
acetazolamide reduced the activity of NBCe1-A operating with
a 1:3, but not a 1:2 Na+:HCO−3 stoichiometry. The authors
proposed that phosphorylation of S982, which is responsible for
the stoichiometry change to 1:2 (Gross et al., 2002), eliminates CA
binding to NBCe1-A. Interestingly, S982 lies in close proximity
to a predicted CA binding site 986DNND, which is similar to the
CAII-binding sequence DADD of AE1 (Vince and Reithmeier,
1998).
The Kurtz group proposed that 958LDDV was another CAII-
binding site in NBCe1-A (Pushkin et al., 2004). Pushkin et al.
(2004) used pull-down assays and measured acetazolamide-
sensitive currents for NBCe1 constructs expressed in a mouse
proximal tubule cell line, where heterologously expressed
NBCe1-A displays a 1:3 Na+:HCO−3 stoichiometry (Gross et al.,
2001a,b). The authors found that the degree of acetazolamide
inhibition of NBCe1 correlated with the degree of CAII/NBCe1-
A binding. NBCe1-A mutants that bound CAII weakly were
more insensitive to acetazolamide than wild-type NBCe1-A,
which displayed the strongest CAII binding. In the proposed
model, 958LDDV and 986DNND are part of a single binding
site. Indeed, according to results from isothermal titration
calorimetry, human kidney NBCe1-A has 1 high-affinity binding
site for CAII with a binding constant of 160 nM (in protein-
free PBS buffer) (Gross et al., 2002). CAII activity also appears
to stimulate other NBCe1 variants. Expressing a catalytically
reduced CAII mutant in HEK293 cells reduced the activity of
co-expressed NBCe1-B (Alvarez et al., 2003).
Similar to CAII regulation of AE1, direct binding of
CAII to NBCe1 remains controversial. In the aforementioned
CAII/NBCe1 studies, reducing CAII activity or mutating the
Frontiers in Physiology | www.frontiersin.org 7 June 2015 | Volume 6 | Article 166
Thornell and Bevensee Regulators of Slc4 bicarbonate transporter activity
putative CAII binding site on NBCe1 inhibited NBCe1 activity.
However, injecting Xenopus oocytes with CAII protein failed to
stimulate NBCe1-A (Lu et al., 2006). CAII was functional in
these experiments based on the observation that pHi recoveries
from CO2-induced acidifications were faster and were inhibited
by the membrane-permeant CAII inhibitor ethoxzolamide. In
additional experiments, the authors found that CAII fused to
a GFP-tagged NBCe1-A construct (eGFP-NBCe1-A) displayed
no enhanced NBC activity over the control eGFP-NBCe1-A
construct. Furthermore, no co-localization of NBCe1-A and
endogenous CAII was evident compared to that seen with CAII
synthetically conjugated to NBCe1-A. Discrepancies in these
findings from those of the Pushkin et al. study may reflect
different cell type-dependent NBCe1 stoichiometries. NBCe1-
A has a 1:2 Na+:HCO−3 when expressed in Xenopus oocytes
(Heyer et al., 1999; Sciortino and Romero, 1999; McAlear et al.,
2006), but a 1:3 Na+:HCO−3 stoichiometry when expressed in the
proximal tubule cell line used in the Pushkin et al. study (Gross
et al., 2001a).
In a more recent Xenopus oocyte study, Schueler et al. (2011)
found that CAI-CAIII all stimulated NBCe1-A-mediated pHi
recoveries and currents when oocytes were held at −40mV.
CAI lacks the putative N-terminal residues for NBCe1-A binding
(3HH. . . 9KH. . . 15H. . . 17H), and CAIII has alternative residues
3E and 9S within this domain (Schueler et al., 2011). Thus, these
experiments support the contention that an interaction is not
necessarily required for CA stimulation of NBCe1.
CAIV, an outer plasma membrane
glycosylphosphatidylinositol-anchored CA, also stimulated
NBCe1-B co-expressed in HEK293 cells (Alvarez et al.,
2003). The authors also showed by pull-down assays and
immunodetection that CAIV —obtained by lysing CAIV-
expressing cells— bound to GST-conjugated NBCe1-B. CAIV
binding to and functional stimulation of NBCe1-B was
dependent on residue G767 found in the fourth extracellular
loop of NBCe1-B that is conserved in CAIV-binding AE1, but
not in AE3 (Alvarez et al., 2003). CAIV is expected to stimulate
all NBCe1 variants, which have this conserved glycine at
position 767.
Autoregulation
When expressed in Xenopus oocytes, NBCe1-A has ∼four-fold
greater activity than NBCe1-B or -C (McAlear et al., 2006).
NBCe1-A differs from NBCe1-B and -C at its N terminus
(Figure 4), and removing this different N terminus reduces
NBCe1-A activity by approximately half. Thus, there appears to
be an autostimulatory domain (ASD) within this N terminus of
the A variant that stimulates activity. The ASD is also expected
to contribute to the activity of NBCe1-D, which has the same N
terminus (Figure 4). Currently, there are no known regulators of
the ASD. This ASD may contribute to the efficient reabsorption
of HCO−3 in the kidney by promoting high-velocity NBCe1-A-
mediated transport of HCO−3 across the basolateral membrane in
the proximal tubule.
Autoregulation has also been demonstrated for the N
terminus of NBCe1-B and -C. Truncating the N terminus of
NBCe1-C stimulated the transporter 2.7-fold (McAlear et al.,
2006). Furthermore, the activity of this truncated variant was
similar to that of the corresponding NBCe1-A truncation (i.e.,
they had similar whole oocyte currents). Therefore, the N
terminus of NBCe1-B or -C appears to contain an autoinhibitory
domain (AID). As described below, this AID is at least partially
regulated by other binding proteins, especially inositol 1,4,5-
trisphosphate (IP3) receptor binding protein released with
IP3 (IRBIT). NBCe1-E is also predicted to have an AID
because it contains the same N terminus as NBCe1-B and -C
(Figure 4).
The specific C terminus of NBCe1-C may also influence
regulation by the AID based on the following two observations
with NBCe1 stimulators soon to be discussed. First, co-
expressing IRBIT in oocytes stimulated co-expressed NBCe1-C
to a greater extent (i.e., more relief of the AID) than NBCe1-B
(Thornell et al., 2010). Second, removing the AID-containing N
terminus of NBCe1-C —but not NBCe1-B— resulted in a small
but significant IP3-induced stimulation that required ER-store
Ca2+ (Thornell et al., 2012). Based on these observations, the C
terminus of NBCe1-C either contributes to a joint N-terminal/C-
terminal AID or contains a separate AID.
IRBIT-WNK/SPAK
IRBIT is a ubiquitous second messenger protein that binds to the
IP3 receptor and competes with intracellular IP3 (Ando et al.,
2003). IRBIT released from the IP3 receptor into the cytosol
regulates many proteins, including channels and transporters
(Ando et al., 2014). When heterologously expressed in Xenopus
oocytes, IRBIT stimulated human NBCe1-B, but not NBCe1-
A (Shirakabe et al., 2006). In similar oocyte co-expression
experiments, IRBIT also stimulated rat NBCe1-B and -C, but
not mutants with N-terminal truncations (Thornell et al., 2010).
In co-immunoprecipitation studies, IRBIT bound to NBCe1-
B, but not NBCe1-A (Shirakabe et al., 2006)— data consistent
with IRBIT binding to the different N terminus of the B and
C variants. Mutating the phosphorylated residue S68 or S71 in
IRBIT’s PEST domain to an Ala still enabled IRBIT to bind to the
IP3 receptor (Ando et al., 2009). However, these mutants failed to
bind to and stimulate NBCe1-B (Shirakabe et al., 2006), and failed
to stimulate NBCe1-C (Thornell et al., 2012). Thus, there are
different regions of IRBIT responsible for IP3 receptor binding
and NBCe1 stimulation.
Results from pull-down assays comparing the binding of
IRBIT to different serial truncations of NBCe1-B indicated that
amino acid regions 1–18 and 37–62 were necessary for IRBIT
binding (Shirakabe et al., 2006). In expression studies with
HeLa cells, Hong et al. (2013) demonstrated that a stretch of
arginines (42–44) within the positively charged region 37–65
of NBCe1-B is required for IRBIT binding and stimulation.
Double, triple, but not single, arginine to alanine replacements
greatly reduced IRBIT binding, while the triple replacement
eliminated IRBIT stimulation of transport. In addition to these
basic arginine residues, T49 is also required for IRBIT regulation.
In a separate study, NBCe1-B amino acid residues between 4 and
16 were also required for IRBIT stimulation (Lee et al., 2012c).
These functional data support Shirakabe et al.’s prediction that
the IRBIT binding and stimulatory determinants of NBCe1-B
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involve multiple motifs within a complex tertiary structure rather
than a single motif (Shirakabe et al., 2006).
Seki et al. (2008) proposed that IRBIT stimulates NBCe1-
B by removing the AID inhibition. If true, then expressing
IRBIT and removing the AID should stimulate NBCe1 activity
to the same extent. IRBIT contains a binding domain for protein
phosphatase-1 (PP-1) (Devogelaere et al., 2007). As such, it is
difficult to activate IRBIT fully because it is normally inhibited by
the ubiquitous phosphatase PP-1. To activate IRBIT maximally,
the Boron group mutated IRBIT’s PP-1 binding site to create
a super-IRBIT (Lee et al., 2012c). The activity of NBCe1-B
co-expressed with super-IRBIT exceeded the activity of the N-
terminal truncation of NBCe1-B lacking the putative N-terminal
AID (Lee et al., 2012c). The authors concluded that IRBIT did
not stimulate NBCe1-B through relief of the AID exclusively.
The AID’s tertiary structure may include other parts of the
transporter, such as a putative C-terminal AID as mentioned
above.
IRBIT and its binding partner PP-1 are linked to other
regulatory molecules (Figure 5). PP-1 antagonizes the
WNK (with-no-lysine kinase)/SPAK (STE20/SPS1-related
proline/alanine-rich kinase) pathway (Yang et al., 2011). Human
WNK/SPAK mutations cause hypertension— a finding that
implicates this pathway as a regulator of epithelial electrolyte
transport (Wilson et al., 2001). Indeed, WNK/SPAK regulates
many epithelial ion channels and transporters including
the Na/K/2Cl cotransporter (Anselmo et al., 2006), the
epithelial sodium channel (Heise et al., 2010), the cystic fibrosis
transmembrane conductance regulator (Yang et al., 2007), the
renal outer medullary K+ channel (He et al., 2007), and NBCe1-B
and -C (Yang et al., 2009).
In HeLa cells, the WNK/SPAK pathway also inhibits NBCe1-
B (Yang et al., 2011; Hong et al., 2013). Transfecting either
WNK or kinase-dead WNK mutants inhibited NBCe1-B—
consistent with WNK acting as a scaffold, not a kinase, for
another NBCe1 regulator such as SPAK (Yang et al., 2011). Co-
transfecting kinase-dead SPAK with WNK blocked the WNK-
mediated inhibition of NBCe1. The phosphorylation of S65 by
SPAK was required for the SPAK-mediated decrease in NBCe1-B
surface expression (Hong et al., 2013). These data are consistent
with WNK recruiting SPAK to phosphorylate NBCe1-B and to
reduce NBCe1-B surface expression. This WNK/SPAK-mediated
FIGURE 5 | Regulators of NBCe1. The general position(s) of known or
approximate target site(s) within NBCe1 for each regulator is/are shown.
Stimulatory effects are depicted by green arrows and inhibitory effects are
depicted by red lines. The N terminus of NBCe1-B and -C that contains the
autoinhibitory domain is shown in red, and the different N terminus in -A that
contains the autostimulatory domain is shown in green. The different C
terminus of NBCe1-C (vs. -A/B) that contains a possible autoinhibitory
domain is shown in red. Direct binding of carbonic anhydrase to the C
terminus remains controversial. The target site of STCH is unknown within
the cytosolic N-terminal residues 96–440 of NBCe1-B. Ser/Thr kinase
involves a site within the different N terminus of the B/C variants. Additional
regulators listed are not as well characterized, especially regarding their
target sites on NBCe1. These additional regulators in black type can be
either stimulatory or inhibitory. Regulatory effects involve changes in transport
function and/or plasma membrane expression, and may be variant
dependent. The NBCe1 topology is based on that presented in Parker and
Boron (2013). CA, carbonic anhydrase; IP3, inositol 1,4,5-trisphosphate;
IP3R, IP3 receptor; IRBIT, IP3R binding protein released with IP3; PIP2,
phosphatidylinositol 4,5-bisphosphate; PKA, protein kinase A, PKC, protein
kinase C; PLC, phospholipase C; PP-1, protein phosphatase 1; SPAK,
STE20/SPS1-related proline/alanine-rich kinase; STCH, Hsp70-like stress 70
protein chaperone; WNK, with-no-lysine kinase.
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NBCe1-B inhibition was antagonized by IRBIT recruitment of
the phosphatase PP-1 (Yang et al., 2011; Hong et al., 2013).
The phosphorylation of NBCe1-B residue T49 is also required
for both the IRBIT and WNK/SPAK pathways, and the T49A
substitution eliminated regulation by both proteins (Hong et al.,
2013). The WNK/SPAK and IRBIT/PP-1 pathways have also
been reported to converge with the regulator PIP2, which also
appears to require the positively charged N terminal region 37–
65 (Hong et al., 2013). However, the IP3/Ca2+ pathway may be
involved. In summary, whereas IRBIT stimulates NBCe1-B and
-C, WNK/SPAK antagonizes these NBCe1 variants (see review
by Park et al., 2012). In addition to the direct IRBIT stimulation
of NBCe1, IRBIT indirectly disinhibits NBCe1 fromWNK/SPAK
by recruitment of PP-1. This signaling complex likely regulates
fluid and electrolyte transport in the pancreatic duct (Yang
et al., 2009, 2011; Park et al., 2012). For example, purinergic
hormones and cholecystokinin that stimulate pancreatic HCO−3
secretion through an increase in intracellular IP3 are expected to
displace IRBIT from the IP3 receptor. This cytosolic IRBIT now
inhibits WNK/SPAK and increases basolateral NBCe1 activity
(responsible for HCO−3 uptake from the interstitium), as well as
apical CFTR and Slc26a6 activities (both responsible for HCO−3
transport into the duct). We recommend Lee et al. (2012a) for a
more detailed description of pancreatic HCO−3 secretion.
IRBIT’s effect on NBCe1-B surface expression depends on
the expression system. Co-expressing IRBIT and NBCe1-B in
Xenopus oocytes did not change surface NBCe1 protein assayed
by confocal imaging (Shirakabe et al., 2006), single-oocyte
chemiluminescence (Thornell et al., 2010), or biotinylation and
subsequent immune-detection (Lee et al., 2012c). However,
IRBIT increased NBCe1-B surface expression in HeLa cells
(Yang et al., 2011). The basis of this discrepancy may be a
less active WNK/SPAK pathway in oocytes than HeLa cells. If
so, then the majority of NBCe1-B would already be expressed
on the oocyte membrane, and only an expression-independent
increase in transporter current is observed. Consistent with this
explanation, co-expressing NBCe1-B and IRBIT in HeLa cells
suppressed WNK/SPAK-mediated NBCe1 internalization and
stimulated NBCe1-B by a WNK/SPAK-independent mechanism
(Hong et al., 2013)— most likely by the expression-independent
mechanism characterized for IRBIT and NBCe1 in oocytes.
PIP2
Phosphatidylinositol 4,5-bisphosphate (PIP2) is a minor
membrane phospholipid involved in many cellular processes
including the regulation of channels and transporters (Di Paolo
and De Camilli, 2006; Balla, 2013). The rat-kidney NBCe1-A
current displays rundown in a macropatch of Xenopus oocyte
membrane that can be inhibited and reversed by directly
applying a fast membrane incorporating short-chain PIP2 (Wu
et al., 2009). In addition, NBCe1-A current rundown is inhibited
by vanadate and Mg2+-free solutions. These data are consistent
with an initial, endogenous PIP2-dependent transporter current
that rapidly decays due to Mg2+-sensitive phosphatase activity
that decreases PIP2.
These findings in isolated membrane patches have been
extended to the whole oocyte. Injecting exogenous PIP2 into an
oocyte to raise PIP2 is not straightforward because the injected
PIP2 is rapidly hydrolyzed to IP3 by phospholipase C (PLC)
(Thornell et al., 2012). Nonetheless, blocking PIP2 hydrolysis by
pretreating the oocyte with the PLC inhibitor U73122 resulted
in a modest PIP2 injection-induced stimulation of NBCe1-
A, -B, and -C (Thornell et al., 2012). Importantly, NBCe1-A
was not stimulated by the PIP2 injection in the absence of
U73122. Therefore, the PIP2-induced stimulation observed in
the presence of U73122 was not the result of incomplete PLC
inhibition. The modest PIP2-induced stimulation of NBCe1 may
indicate that PIP2 is near it maximal effective concentration in
oocytes. As such, decreasing PIP2 may be a better assay for
exploring PIP2 regulation of NBCe1.
We have recently found that a decrease in membrane PIP2
itself —independent of IP3— inhibits NBCe1-B and -C expressed
in Xenopus oocytes (Thornell and Bevensee, 2015). Degrading
PIP2 was achieved by co-expressing NBCe1 with a voltage-
sensitive phosphatase (VSP) that dephosphorylates PI(4,5)P2 to
PI(4)P. Activating VSP by sufficient depolarization inhibited
NBCe1-B and -C. Importantly, depolarizing oocytes to voltages
that do not sufficiently activate the VSP, or using a phosphatase-
dead mutant (C366S VSP) did not inhibit NBCe1-mediated
currents or pHi recoveries from an acid load. Furthermore, in
simultaneous voltage-clamp and confocal imaging experiments
with a PIP2-sensitive fluorescent probe, VSP-elicited changes in
NBCe1 current mirrored PIP2 changes in the plasma membrane.
Where might PIP2 bind to NBCe1? Based on crystallography
data of the Kir2.2-PIP2 and the GIRK2-PIP2 interactions
(Hansen et al., 2011; Whorton and MacKinnon, 2011), these
K+ channels have a non-specific phospholipid domain within
the transmembrane (TM) region, as well as a polycationic
PIP2 binding domain in the cytosol near one TM region.
NBCe1 variants contain similar PIP2-binding motifs, including
KDKKKKEDEKKKKKKK in the cytosolic C-terminus, RKHRH
in the cytosolic N terminus, and RKEHKLKK before TM8. The
region before TM8 is of particular interest because TM8 is
involved in ion translocation (McAlear and Bevensee, 2006). An
additional PIP2-binding motif, RRRRRHKRK is found in the
N terminus of NBCe1-B and -C. Recently, Hong et al. (2013)
reported that a trimer of arginines (42–44) within this region is
required for PIP2 stimulation of NBCe1-B. However, this region
may play a role in IP3/Ca2+ regulation instead. This region is
unlikely to be the sole PIP2-binding region because it is absent
in the PIP2-sensitive NBCe1-A.
IP3 and Ca
2+
Injecting PIP2 into whole Xenopus oocytes expressing NBCe1-B
or -C, but not NBCe1-A, stimulated the NBC current (Thornell
et al., 2012). The majority of this stimulation was mediated by
PIP2 hydrolysis to IP3, required an intracellular Ca2+ store, and
involved a staurosporine-sensitive Ser/Thr kinase (Thornell et al.,
2012). Raising intracellular Ca2+ (e.g., by applying ionomycin
and activating membrane Ca2+ channels and Gq-coupled
receptors) also stimulated the B and C variants. This mode of
stimulation also required the distinct N terminus of the B/C
variant. Thus, kinase-mediated phosphorylation of NBCe1 or an
NBCe1 regulator may relieve the N-terminal AID. As previously
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reported, such a kinase pathway may also be responsible for
observed ATP stimulation of NBCe1-A in the macropatch
(Heyer et al., 1999). Activating endogenous Gq-coupled receptors
in Xenopus oocytes by applying lysophosphatidic acid (LPA)
stimulated the activity of heterologously expressed NBCe1-C.
However, LPA stimulated the activity of heterologously expressed
NBCe1-B by an increase in expression in physiological conditions
(Thornell et al., 2012). In recent experiments, LPA stimulated
NHE3 expression through the Ser/Thr kinase p90 ribosomal
S6 kinase (RSK) (No et al., 2015). These similarities raise the
possibility that RSK may be involved in LPA-induced stimulation
of at least NBCe1-B.
NBCe1-A expressed in whole Xenopus oocytes was minimally
stimulated by PIP2 injection, and unaffected by raising
intracellular Ca2+, e.g., by activating store-operated Ca2+
channels (Thornell et al., 2012). However, in a separate study,
raising bath Ca2+ from 100 to 500 nM stimulated the slope
conductance of rat NBCe1-A in a fraction of inside-out oocyte
macropatches. Based on I-V data, the stimulation involved an
increase in the stoichiometry from 1:2 to 1:3 Na+:HCO−3 (Müller-
Berger et al., 2001). Thus, Ca2+ regulation of NBCe1-A is clearly
different in the whole cell vs. at least a fraction of isolated
membrane patches.
PIP2 vs. IP3/Ca
2+
The aforementioned evidence that PIP2 can stimulate all three
NBCe1 variants directly, or NBCe1-B and -C indirectly through
its hydrolysis and subsequent IP3/Ca2+, raises the question of
which is the dominant pathway (Thornell and Bevensee, 2015).
This dual mode of regulation is similar to that reported for the
KCNQ-mediatedM current in superior cervical ganglion cells
(Zhang et al., 2003; Gamper et al., 2004; Suh and Hille, 2005;
Winks et al., 2005; Zaika et al., 2011). We believe the inhibitory
effect of PIP2 hydrolysis will dominate when Gq receptors are
activated away from a Ca2+ source. Thus, there is no Ca2+ release
that can activate lipid kinases that normally replenish the PIP2.
In contrast, the stimulatory effect of PIP2 hydrolysis to IP3/Ca2+
will dominate when the receptors are activated near a Ca2+
source. Alternatively, the IP3/Ca2+ pathway may predominate
under physiological conditions with adequate energy levels.
However, the PIP2 pathway would play the dominant role with
energy (ATP) depletion, for example, associated with anoxia or
hypoxia. An associated decrease in PIP2 may inhibit transporters
such as NBCe1 in a protective way to minimize large intracellular
Na+ and Ca2+ loads and/or to conserve remaining energy.
Such inhibition may counteract the deleterious effect of NBCe1
stimulation in the ischemic heart as described above. Finally, as
suggested by Hilgemann et al. (2001), the PIP2 requirement for
NBCe1 function may keep the transporters necessarily inactive
during maturation and trafficking through organelles prior to
expression at the plasma membrane.
Angiotensin II, PKC, and Ca2+
It is well established that endogenous NBCe1-A is stimulated by
low concentrations (10−11–10−9M) of angiotensin II (Ang II)
and inhibited by high concentrations (10−9–10−6M) of Ang II
(Geibel et al., 1990; Eiam-Ong et al., 1993; Coppola and Frömter,
1994; Ruiz et al., 1995; Robey et al., 2002; Zheng et al., 2003). Ang
II-mediated bimodal regulation has been reported for NBCe1-
A heterologously expressed in Xenopus oocytes co-expressing
the Ang II receptor AT1A (Perry et al., 2006, 2007). Low
concentrations of Ang II increased the depolarization-induced
NBCe1 current through a Ca2+-dependent mechanism that
could be inhibited by BAPTA (Perry et al., 2006). However, high
concentrations of Ang II inhibited this NBCe1 current through a
pathway involving Ca2+-insensitive protein kinase C, PKCε that
reduced expression at the plasma membrane (Perry et al., 2006,
2007). Interestingly, both a PKCε inhibitor and the Ca2+ chelator
BAPTA reduced the high Ang II-mediated NBCe1 inhibition,
perhaps through separate pathways. Furthermore, the Ang II-
induced inhibition was irreversible after applying calmodulin
inhibitors or monensin— a finding consistent with high Ang
II inhibiting NBCe1-A trafficking to the plasma membrane in
oocytes. Thus, results from heterologous expression studies have
provided mechanistic insight into the concentration-dependent,
Ang II-mediated bimodal regulation of endogenous NBCe1 in
kidney.
Acetylcholine
Acetylcholine (ACh) is a neurotransmitter that activates
either ionotropic or metabotropic receptors. Metabotropic ACh
receptor activation promotes anion secretion in many epithelial
cell types such as acinar cells in the pancreas (Steward and
Ishiguro, 2009; Lee et al., 2012a). Curiously though, applying
carbachol lowered membrane expression of both transiently
expressed NBCe1-A and NBCe1-B in acinar ParC5 cells (Perry
et al., 2009). Furthermore, contradictory to secretion observed
in native tissue, pretreating NBCe1-B-expressing HEK293 cells
with carbachol did not alter NBCe1-B activity (Bachmann et al.,
2008). The paradoxical findings may be the result of NBCe1
overexpression or cell-type specific cAMP-mediated pathways,
which can merge with metabotropic ACh signaling and jointly
regulate anion secretion (e.g., in the pancreas, Lee et al., 2012a).
cAMP
cAMP is a second messenger formed by adenylate cyclase (AC)-
mediated catalysis of ATP. It is well established that a hormone-
induced increase in cAMP decreases renal tubular HCO−3
absorption and increases pancreatic duct HCO−3 secretion
(McKinney and Myers, 1980; Liu and Cogan, 1989; Ishiguro
et al., 1996a,b; Kunimi et al., 2000). However, less is known about
the molecular mechanisms by which cAMP alters the activity of
NBCe1— the dominant Na+-coupledHCO−3 transporter in these
tissues.
There is evidence that cAMP can contribute to a change in
transport stoichiometry of NBCe1 from 1:3 to 1:2 Na+:HCO−3
through protein kinase A (PKA)-mediated phosphorylation of
either S982 of the A variant or the homologous S1026 of
the B variant (Gross et al., 2001a,b, 2003). Furthermore, the
base stoichiometry and response to cAMP of NBCe1-A and -
B have been reported to be cell-type dependent (Gross et al.,
2003). In the kidney proximal tubule, this stoichiometry change
would account for observed inhibition of net HCO−3 eﬄux by
cAMP-elevating dopamine (Kunimi et al., 2000) and parathyroid
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hormone (McKinney and Myers, 1980). However, it is now
clear that the regulation of NBCe1 stoichiometry is complex
and not fully understood. For example, additional factors
can influence NBCe1 stoichiometry, including intracellular
Ca2+ (see above, Müller-Berger et al., 2001), other residues
such as T485 (A variant), which is part of putative TM3
(Zhu et al., 2013), and even assay-dependent measurements
(Zhu et al., 2013).
cAMP can also stimulate NBCe1-B activity, as indicated by
an increase in slope conductance, without an apparent change in
stoichiometry (Gross et al., 2003). cAMP stimulation of NBCe1-
B required residue T49 located in the PKA phosphorylation site
of the different N-terminus, although did not require a change
in its phosphorylation state. Curiously, this Thr at position
49 in human NBCe1-B is not conserved across species, and
is an Ala in rat NBCe1-B. This mode of cAMP stimulation
was also observed for NBCe1-B expressed in mPT cells as
indicated by an increase in slope conductance (in addition to
the reversal potential shift described above). Secretin-induced
HCO−3 secretion by the pancreatic duct may be due, at least
in part, to cAMP stimulation of NBCe1-B in the basolateral
membrane (Ishiguro et al., 1996a,b).
Magnesium
Free cytosolic Mg2+ remains fairly constant in a variety
of physiological conditions— ranging from 0.5 to 0.7mM
(Romani, 2007). Yamaguchi and Ishikawa (2008) expressed
bovine NBCe1-B in HEK293 and NIH3T3 cells, and
monitored whole-cell Na+-dependent HCO−3 currents by
patch clamping while varying the Mg2+ concentration in the
pipette solution. For HEK293 cells, Mg2+ inhibited Na+-
dependent HCO−3 currents with Ki values that appeared
voltage-independent (e.g., ∼15µM at −20mV, ∼11µM at
+20mV, and ∼11µM at +40mV). A similar Mg2+-induced
NBCe1-B inhibition was observed for NIH3T3 cells. The AID
of NBCe1-B was involved because an N-terminal truncation of
NBCe1-B raised the Ki for Mg2+ to 300µM.
Endogenous NBCe1-B in bovine parotid acinar cells was also
inhibited byMg2+ with∼eight-fold higher Ki values (Yamaguchi
and Ishikawa, 2008). The rightward shift in Ki from the previous
expression systems was likely due to cell-type specific regulation.
For example, IRBIT co-transfection increased the Ki for Mg2+-
induced inhibition of NBCe1-B stably transfected into HEK293
cells from 560 nM to 11µM (Yamaguchi and Ishikawa, 2012).
However, it is not clear why the Ki for Mg2+-induced NBCe1-
B inhibition in this study was lower than in the previous study
(Yamaguchi and Ishikawa, 2008).
Mg2+ may inhibit NBCe1-B by disrupting PIP2 stimulation
of the transporter. More specifically, the cationic Mg2+ may
screen the negative charges of PIP2 (Suh and Hille, 2007),
which we have recently shown to stimulate NBCe1 (Thornell
et al., 2012; Thornell and Bevensee, 2015). Consistent with
this mechanism, other polyvalent cations such as neomycin
(Yamaguchi and Ishikawa, 2008) and spermine (Yamaguchi and
Ishikawa, 2012) increased the Ki for Mg2+-induced inhibition
of NBCe1-B heterologously expressed in HEK293 and NIH3T3
cells, and endogenously expressed in bovine parotid acinar cells.
Such polycations also inhibit PIP2 stimulation of NBCe1-A (Wu
et al., 2009).
Although it is well established that Mg2+ interacts and
regulates ion channels and transporters, including the Na-K and
Ca2+ pumps Jorgensen et al., 2003; Lu, 2004; Romani, 2007, it
is intriguing that Mg2+ also regulates NBCe1, and perhaps other
NCBTs. Such regulation by divalents other than Ca2+ may play a
much larger role than previously thought in acid-base handling
in organs such as the kidney. As described above, cytosolic Mg2+
is relatively stable under physiological conditions. However, it
can rise to over 1.0mM under pathological conditions such as
ischemia (Murphy et al., 1989). Perhaps elevated Mg2+-induced
inhibition of NBCe1 protects cells in pathological states by
minimizing large intracellular Na+ and Ca2+ loads— similar to
that proposed above for PIP2 hydrolysis-induced inhibition of
NBCe1.
Chloride
In a recent study, Shcheynikov et al. (2015) reported that
intracellular Cl− (Cl−i ) is a signaling ion that regulates NBCe1-A
and -B, as well as NBCe2-C expressed in HeLa cells. High Cl−i
inhibits NBCe1-B and involves two GxxxP sites in the cytosolic N
terminus. One is a low-affinity site active under basal conditions,
whereas the other is a high-affinity site unmasked by IRBIT.
Interestingly, NBCe1-A is insensitive to Cl−i in the physiological
range, but does contain a single, low-affinity GxxxP site in its
N terminus that can be unmasked by deleting residues 29–41.
NBCe2-C has a single, high-affinity GxxP in its cytosolic N
terminus that is basally active. Cl−i regulation of NBCe1 appears
to be cell-type dependent because IRBIT stimulates NBCe1-B
expressed in oocytes, which have a high Cl−i [∼35mM (Cooper
and Fong, 2003)]. This oocyte Cl− concentration inhibits the
transporter in HeLa cells under the same conditions. As the
authors propose, Cl−i regulation of NBCe1-B could serve to
couple NBCe1 and AE activity in a negative feedback fashion,
and to promote continued HCO−3 secretion by epithelia in
distal portions of ducts (e.g., salivary and pancreatic) where Cl−i
is low.
Chaperone Stress 70 Protein (STCH)
Chaperone stress 70 protein (STCH) is a ubiquitously expressed
microsomal-associated protein whose cellular function is poorly
understood (Bae et al., 2013). Although a member of the 70-
kDa heat-shock protein family, STCH is not activated by heat
shock. STCH is expressed ubiquitously and activated by Ca2+.
STCH binds to NBCe1-B based on results from a yeast 2-hybrid
screen (Bae et al., 2013). Co-expressing STCH with NBCe1-B in
Xenopus oocytes caused an increase in transporter current due to
enhanced protein expression. The N terminus of NBCe1 was not
involved because STCH co-expression also stimulated an NBCe1
truncated at its N terminus (195aa). Furthermore, STCH and
IRBIT stimulation of NBCe1-B was additive in co-expression
studies, and therefore likely involve separate pathways. STCH
stimulation of endogenous NBCe1-B was evident in a human
submandibular gland ductile cell line, HSG (Bae et al., 2013).
siRNA knockdown of STCH in HSG cells inhibited a DIDS-
sensitive pHi recovery from an NH
+
4 -induced acid-load, and
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decreased membrane expression of NBCe1-B. Bae et al. (2013)
noted that STCH is down regulated in some cancers and central
nervous system disorders, and the reduced stimulation of NBCe1
would promote cellular acidification.
Regulators of cloned NBCe1 variants are shown in Figure 5.
NBCn1 (Slc4a7)
NBCn1 variants are found inmany tissue types and are regulators
of pHi. Additionally, NBCn1 is involved in coordinating
epithelial absorption and secretion of solutes. There are 16
identified functional NBCn1 splice variants, NBCn1-A through
-P. These splice variants are simplified by grouping variable
regions into cassettes (Figure 6). Each functional variant contains
1 of 2 alternate N-termini, and includes or excludes previously
defined cassette I, II, and/or IV in the N terminus, and/or cassette
III in the C terminus (Liu et al., 2013).
NBCn1 knockout mice and genomic data have been useful in
identifying tissue-specific roles for NBCn1. The transporter plays
a major role in somatosensory perception based on the finding
that NBCn1 knockout mice exhibit blindness and hearing loss
(Bok et al., 2003; Lopez et al., 2005). NBCn1 dysfunction is also
a risk factor for hypertension in humans (Ehret et al., 2011), and
this link complements the phenotype of mild hypertension in the
NBCn1 knockout mouse (Boedtkjer et al., 2011).
Autoregulation
In a detailed oocyte expression study, Liu et al. (2013) discovered
that eachNBCn1N-terminal region and cassette influences either
membrane surface expression or activity of the transporter as
measured by a pHi recovery from a cellular acid load. TheMEAD
N terminus (Figure 6; gray N-terminus) increased NBCn1
surface expression, but not transporter activity, as compared
FIGURE 6 | Alignment of NBCn1 variants. NBCn1 variants are identical
except for a mixture of different variable N termini (N), a 13-residue cassette I in
the cytoplasmic N-terminal region, a 123-residue (mouse or rat) or a
124-residue (human) cassette II in the cytoplasmic N-terminal region, a
20-residue cassette IV in the cytoplasmic N-terminal region, and/or a
36-residue cassette III in the cytoplasmic C-terminal region.
to the MERF N terminus. Cassettes I, II, and III regulated
surface expression by interacting with multiple cassettes, thereby
making it difficult to assign a specific role to any single cassette.
Cassette I tended to promote surface expression, but did not
stimulate transporter activity. Cassette II stimulated NBCn1
activity 3.8-fold, and cassette III stimulated activity by 4.4-fold.
Cassette IV had themost dramatic regulatory effect— stimulating
NBCn1 activity ∼11-fold, while inhibiting protein membrane
abundance by 55%.
Carbonic Anhydrase
CAII binding to NBCn1 is controversial as discussed above for
AE1 and NBCe1. Similar to the findings with AE1, HEK293
cells co-expressing NBCn1 and a catalytically reduced CAII
mutant have a slower pHi recovery from an acid load than
cells expressing NBCn1 alone (Loiselle et al., 2004). However,
untagged NBCn1 did not bind CAII, as described for AE1
(Piermarini et al., 2007).
Calcineurin
Calcineurin is a calcium-dependent Ser/Thr protein phosphatase
found in many cell types (Rusnak and Mertz, 2000). Calcineurin
interacts with cassette II of NBCn1 based on results from
a yeast 2-hybrid screen of a human skeletal muscle cDNA
library (Danielsen et al., 2013). According to further mutagenesis
work, this interaction is dependent on residues 94PTVVIHT
(critical amino acids are underlined) within cassette II of
NBCn1. Results from surface plasmon resonance further support
calcineurin binding and a subsequent conformational change
of cassette II of NBCn1 (Gill et al., 2014). Regarding function,
raising intracellular Ca2+ to activate calcineurin stimulated the
endogenous NBCn1-B-mediated pHi recovery from an acid load
in smooth muscle cells of rat mesenteric arteries (Danielsen
et al., 2013). This stimulation was inhibited by the Ca2+ chelator
BAPTA and calcineurin inhibitors FK506 and cyclosporine in a
non-additive fashion. Based on the modular structure of NBCn1,
cassette II is found in many variants (Boron et al., 2009) and
calcineurin is expected to stimulate NBCn1-A, -B, -C, -D, and
-H (Figure 6). Calcineurin stimulation of NBCe1-B is likely
physiologically important by protecting the smooth muscle cells
from excessive acidosis during artery contraction (Danielsen
et al., 2013).
IRBIT
As described above, IRBIT is a signaling molecule released
from IP3 receptors when the cytosolic IP3 concentration
rises (Ando et al., 2003). Parker et al. (2007b) demonstrated
that IRBIT interacts with NBCn1-B and stimulates both the
transport activity and channel-like Na+ conductance of NBCn1-
B expressed in Xenopus oocytes. This IRBIT stimulation is
not due to increased NBCn1-B expression (Mark D. Parker,
personal communication). IRBIT co-expression in HeLa cells
also stimulates NBCn1-A (Hong et al., 2013). Similar to that
observed for NBCe1-B, this stimulation requires the homologous
trimer of arginines (residues 56–58) within the cytoplasmic N
terminus of NBCn1-A, and involves the PP-1 and WNK/SPAK
pathways. Thus, IRBIT is expected to bind the other NBCn1
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variants that all have the IRBIT binding domain identified in
NBCe1-B.
PIP2
Hong et al. have presented intriguing data that PIP2 also appears
to stimulate NBCn1 expressed in Xenopus oocytes, and the
stimulation requires the trimer of arginines at residues 56–
58 (Hong et al., 2013). Thus, PIP2 regulation of BTs may not
be restricted to NBCe1. However, as presented above for PIP2
studies on NBCe1, it is important to distinguish between the
effects of PIP2 per se vs. its hydrolysis to IP3.
cAMP
cAMP is a second messenger that actives PKA, thereby
phosphorylating many target proteins and activating many
channels and transporters, including NBCe1 described above.
Applying the PKA activators forskolin or 8-bromoadenosine
stimulated NBCn1 heterologously expressed in HEK293 cells
(Loiselle et al., 2004). Although this inhibition was sensitive to the
PKA inhibitor H89, PKA did not alter the phosphorylation state
of NBCn1. Thus, phosphorylation of an intermediate NBCn1
regulatory protein may be involved.
PDZ Domain-containing Proteins
Post-synaptic density protein 95 (PSD-95) is a scaffolding
protein found in the post-synaptic density of neuronal
dendrites. In addition to containing an SH3 domain and a
catalytically inactive guanylate kinase domain, PSD-95 contains
three PDZ domains that interact with other PDZ-containing
proteins including the NMDA receptor (Xu, 2011). Based on
co-immunoprecipitation results, PSD-95 binds to NBCn1,
which contains a PDZ-binding domain (Lee et al., 2012b).
Although co-expressing PSD-95 with NBCn1 did not stimulate
HCO−3 transport, it did stimulate an NBCn1-associated
channel-like conductance (Lee et al., 2012b). Syntrophin γ2
is another cytosolic scaffolding protein that contains a PDZ
domain and binds NBCn1 (Lee et al., 2014). Co-expressing
syntrophin γ2 with NBCn1 stimulated both HCO−3 transport
and the NBCn1-associated channel-like conductance. Thus,
PDZ domain-containing proteins can complex with NBCn1
and alter the pH physiology and/or electrical properties of
excitable cells.
Regulators of cloned NBCn1 variants are shown in Figure 7.
NDCBE (Slc4a8)
NDCBE is present in many organs, but is most abundant in the
brain where it regulates pH and neuronal firing (Sinning et al.,
2011). There are 5 NDCBE splice variants, NDCBE-A through -
E (Figure 8). NDCBE-A and -B contain the same 16 residue N
terminus, but vary in their C termini. NDCBE-C is identical to
NDCBE-A, but is truncated at the N terminus by 54 residues.
NDCBE-D is identical to NDCBE-B, but is truncated at the N
terminus by 54 residues. NDCBE-E is identical to NDCBE-B, but
the 16 residue N terminus of the B variant is replaced by a unique
FIGURE 7 | Regulators of NBCn1. The general position(s) of known or
approximate target site(s) within NBCn1 for each regulator is/are shown.
Stimulatory effects are depicted by green arrows and inhibitory effects are
depicted by red lines. The direct binding of CA to NBCn1 remains
controversial. PIP2 may stimulate itself or following PIP2 hydrolysis. cAMP
(PKA) is an additional regulator that is not as well characterized,
especially regarding its target site(s) on NBCn1. These effects involve
changes in transport function and/or plasma membrane expression, and
may not be the same for all variants. The many splicing cassettes and
their complex combinations that are either stimulatory or inhibitory are not
shown. The NBCn1 topology is based on that presented in Parker and
Boron (2013). CA, carbonic anhydrase; IRBIT, inositol 1,4,5-trisphosphate
(IP3) receptor binding protein released with IP3; PIP2, phosphatidylinositol
4,5-bisphosphate; PKA, protein kinase A; PP-1, protein phosphatase 1;
SPAK, STE20/SPS1-related proline/alanine-rich kinase; WNK,
with-no-lysine kinase.
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FIGURE 8 | Alignment of NDCBE variants. NDCBE variants are identical
except for differences or truncations at the N and/or C termini.
43 residue N terminus. Of the 5 NDCBE variants, only the E
variant has yet to be tested for function (Parker and Boron, 2013).
Autoregulation
NDCBE-B, -D, and -E share a 17-residue C-terminal sequence
(Figure 8). When expressed in Xenopus oocytes, NDCBE-B and
-D have similar activities (Parker et al., 2008). Removing these
17 C-terminal residues of the B variant stimulated transporter
activity to the level of the A variant. These findings are consistent
with an AID within the different C-terminal region of NDCBE-B
and -D.
IRBIT
IRBIT, as described above, binds to and regulates other BTs
including NBCe1 and NBCn1. IRBIT also binds to NDCBE-
B and stimulates the transporter current (Parker et al., 2007b).
However, not all NDCBE variants are stimulated by IRBIT.
Parker and Boron (2013) reported the preliminary finding that
IRBIT does not stimulate NDCBE-D. This variant does contain
the putative IRBIT-binding RRR sequence (residues 19–21).
Thus, additional domains influence IRBIT binding to BTs, as
described above for NBCe1.
NBCn2 (Slc4a10)
NBCn2 is present throughout many organs. A physiological
role for NBCn2 has been most apparent in the brain, where
NBCn2 regulates neuronal firing. The NBCn2 knockout mouse
had impaired neuronal recovery from an acid load and a higher
seizure threshold (Jacobs et al., 2008). However, disruption of
the NBCn2 gene in a human patient is associated with both
epilepsy and mental retardation (Gurnett et al., 2008). The role
of NBCn2 outside of the nervous system remains unclear (Parker
and Boron, 2013). There are four NBCn2 splice variants, NBCn2-
A through -D (Figure 9). NBCn2-B and -D contain a 30-residue
cassette A within the N terminus. NBCn2-A and -B contain a 3-
residue cassette within the C terminus, whereas NBCn2-C and
-D contain a 21-residue cassette within the C terminus that has a
PDZ domain.
FIGURE 9 | Alignment of NBCn2 variants. NBCn2 variants are identical
except for the inclusion/exclusion of a 30-residue cassette, and/or a different
C terminus.
Autoregulation
Removing the N-terminal 92 residues of NBCn2-B increased
transporter activity (Parker et al., 2007a). Thus, this region likely
contains an AID, which is conserved among all the NBCn2
variants (Figure 9). However, the AID may be differentially
regulated by other variable regions among the variants.
cAMP
cAMP inhibits NBCn2-C. Applying forskolin to 3T3 cells
heterologously expressing NBCn2-C (reported as a variant of
NCBE) inhibited the NBCn2-mediated pHi recovery from an
acid load (Lee et al., 2006). The cAMP analog 8-bromo-cAMP
mimicked this inhibition, whereas the PKA inhibitory fragment
14-22 stimulated transport. Disrupting the actin cytoskeleton
with cytochalasin B also inhibited the NBCn2-mediated pHi
recovery. A potential protein that may link cytoskeleton structure
to NBCn2 is the ezrin binding protein 50 (EBP50), which
contains PDZ domains and also binds PKA. Indeed, EBP50 co-
immunoprecipitated with transfected NBCn2-C in 3T3 cells (Lee
et al., 2006). Because NBCn2-C and PKA can bind EBP50, the
authors suggest that cAMP-induced NBCn2-C inhibition is an
upstream regulator of EBP50 PDZ domains. Similar regulation is
expected for NBCn2-D that also has a PDZ-binding domain at its
C terminus.
IRBIT
IRBIT both binds and stimulates NBCn2 (Parker et al., 2007a,b).
IRBIT stimulates NBCn2 without a change in membrane
abundance (Mark D. Parker, personal communication).
Conclusions and Future Directions
Investigators have made considerable advances over the years
in identifying and characterizing regulators of Slc4 BTs. Results
from functional assays, mutagenesis, and binding studies
involving immunoprecipitation and yeast 2-hybrid assays on
the cloned proteins heterologously expressed in oocytes or
mammalian cells have revealed a rich and diverse array
of regulators and their target sites. Regulators can alter
BT expression and/or function, and perhaps even transport
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stoichiometry. In addition to the classic second messengers
(e.g., Ca2+, cAMP, and associated phosphorylation), there are
less conventional regulators. For example, glycolytic enzymes
alter the activity/expression of AE1. Autoregulatory domains
influence the function of many NCBTs, and these include the
N termini of NBCe1 and NBCn2, the C termini of NDCBE,
and cassettes throughout NBCn1. Such autoregulation may
underscore the functional significance of at least some NCBT
variants. Some of these regulators exhibit crosstalk and modulate
each other. IRBIT is a central player in the crosstalk of regulators
already identified for NBCe1. While IRBIT stimulates NBCe1-
B/C (at least partially) by removing the N-terminal AID, it also
suppresses WNK/SPAK inhibition of the transporter. IRBIT also
appears to interfere with Mg2+-induced inhibition and the PIP2
(or IP3/Ca2+)-induced stimulation of NBCe1, perhaps through
the AID as well. Most recently, IRBIT has been shown to promote
Cl−i inhibition of NBCe1-B by unmasking a high-affinity GxxxP
site.
The exciting advances alreadymade will direct future efforts to
understand better the physiological significance of regulators of
Slc4 BTs. Appealing future areas of research involve the following:
(i) Identifying and characterizing new regulators of the cloned
proteins. Other regulators and interacting proteins are
expected to be identified, especially for BTs that contain
PDZ-binding motifs at their C termini. Some regulators
may therefore be variant-specific.
(ii) Addressing controversies, particularly related to the
importance of CAs in BT function, and the existence of a
physical BT-CA metabolon.
(iii) Determining the mechanistic basis of regulators such
as glycolytic enzymes and protein 4.2 that stimulate
AE1, and PIP2 that stimulates NBCe1. Mutagenesis
data will help assign regions involved in binding.
Structural information provided by biochemical techniques
(such as chemical labeling and the substituted-cysteine
accessibility method or SCAM), NMR, and eventual x-ray
crystallography will provide insight into conformational
changes that are directly responsible for altered transport
function.
(iv) Elucidating the dynamic interplay and/or crosstalk among
various regulators (e.g., associated with IRBIT regulation
and PIP2-IP3/Ca2+ regulation). These studies are linked to
(iii) above. However, a challenge will be in distinguishing
regulators as competitors vs. allosteric modulators, and
in determining under what conditions one regulator
dominates. We expect regulatory profiles to differ among
variants in some cases.
(v) Characterizing regulation of endogenous BT function in
a physiological/pathophysiological setting. This direction
is highlighted by the recent evidence that IRBIT and
associated regulators modulate ion and fluid secretion by
ductal epithelia. Additional exciting directions include
determining if high Mg2+i or PIP2 hydrolysis protects
against cell-damaging Na+i and Ca
2+
i overload by inhibiting
NBCe1 in energy-deficient pathological conditions such
as ischemia and hypoxia. For regulators of BTs that
influence the electrical properties of excitable cells (e.g.,
heart myocytes and neurons), it will be important to assess
how such regulators impact overall tissue excitability and
function. Results from in-vivo and in-vitro physiological
studies on specific BT knockout (KO) animals will elucidate
the specific transporters or variants responsible. However,
targeting a specific BT that represents a splice variant will
be genetically challenging in KO studies. Conditional KO
animals will be valuable in assessing the role of specific
transporters/variants without confounding compensatory
expression profiles.
Undoubtedly, the field will continue to evolve with new
discoveries that will highlight the complexity of pHi physiology.
Multiple regulatory mechanisms for a single Slc4 protein and/or
the presence of many different Slc4 proteins impart a cell with an
intricate signaling network to orchestrate pHi regulation under
different conditions and stimuli.
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